Literature DB >> 3148067

Prolinase activity in prolidase-deficient fibroblasts.

G Miech1, I Myara, M Mangeot, V Voigtlander, A Lemonnier.   

Abstract

The activity of prolinase (EC 3.4.13.8) was studied in cultured skin fibroblasts derived from three patients with deficient prolidase (EC 3.4.13.9). With pro-val as substrate and manganese in the reaction buffer, prolinase activity was higher in prolidase-deficient cells than in control cells (mean (SEM) 917 (67) nmol min-1 mg-1, n = 3, control mean (SEM) 294, (50), n = 11). The Michaelis constants were not different for the pro-val and progly substrates in control and prolidase deficient fibroblasts. However, the constants for Vmax rose for both substrates in deficient cells. These results demonstrate that prolinase activity increases in prolidase-deficient fibroblasts as also shown in the plasma of patients with prolidase deficiency. We suggest that in prolidase-deficient fibroblasts, this rise in prolinase activity constitutes an attempt to compensate for the prolidase deficiency by increasing the greatly reduced intracellular proline pool.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148067     DOI: 10.1007/bf01800368

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Presence in human cells and tissues of two prolidases and their alteration in prolidase deficiency.

Authors:  J Butterworth; D A Priestman
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

2.  Plasma prolidase and prolinase activity in prolidase deficiency.

Authors:  I Myara; J F Stalder
Journal:  Clin Chem       Date:  1986-03       Impact factor: 8.327

3.  Some metabolic differences between human skin and aponeurosis fibroblasts in culture.

Authors:  F Lemonnier; M Gautier; C Wolfrom; A Lemonnier
Journal:  J Cell Physiol       Date:  1980-09       Impact factor: 6.384

4.  Substrate specificity of manganese-activated prolidase in control and prolidase-deficient cultured skin fibroblasts.

Authors:  J Butterworth; D Priestman
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  Proline recycling during collagen metabolism as determined by concurrent 18O2-and 3H-labeling.

Authors:  S H Jackson; J A Heininger
Journal:  Biochim Biophys Acta       Date:  1975-02-13

6.  Cell density affects prolidase and prolinase activity and intracellular amino acid levels in cultured human cells.

Authors:  I Myara; C Charpentier; M Gautier; A Lemonnier
Journal:  Clin Chim Acta       Date:  1985-07-30       Impact factor: 3.786

7.  Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria.

Authors:  I Myara; C Charpentier; A Lemonnier
Journal:  Clin Chim Acta       Date:  1982-10-27       Impact factor: 3.786

8.  Prolidase and prolidase deficiency.

Authors:  I Myara; C Charpentier; A Lemonnier
Journal:  Life Sci       Date:  1984-05-21       Impact factor: 5.037

9.  In-vitro responses to ascorbate and manganese in fibroblasts from a patient with prolidase deficiency and iminodipeptiduria: cell growth, prolidase activity and collagen metabolism.

Authors:  I Myara; C Charpentier; C Wolfrom; M Gautier; A Lemonnier; M Larregue; A Chamson; J Frey
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

  9 in total
  2 in total

1.  Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes.

Authors:  F Endo; A Tanoue; A Kitano; J Arata; D M Danks; C M Lapière; Y Sei; S K Wadman; I Matsuda
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases.

Authors:  Francis Rossignol; Marvid S Duarte Moreno; Carlos R Ferreira; Manuel Schiff; Jean-François Benoist; Manfred Boehm; Emmanuelle Bourrat; Aline Cano; Brigitte Chabrol; Claudine Cosson; José Luís Dapena Díaz; Arthur D'Harlingue; David Dimmock; Alexandra F Freeman; María Tallón García; Cheryl Garganta; Tobias Goerge; Sara S Halbach; Jan de Laffolie; Christina T Lam; Ludovic Martin; Esmeralda Martins; Andrea Meinhardt; Isabelle Melki; Amanda K Ombrello; Noémie Pérez; Dulce Quelhas; Anna Scott; Anne M Slavotinek; Ana Rita Soares; Sarah L Stein; Kira Süßmuth; Jenny Thies
Journal:  Genet Med       Date:  2021-05-26       Impact factor: 8.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.